Chemotherapy Plus Surgery in Treating Women With Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 31, 1996

Study Completion Date

March 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

CMF regimen

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

fluorouracil

DRUG

methotrexate

DRUG

paclitaxel

DRUG

tamoxifen citrate

PROCEDURE

conventional surgery

RADIATION

radiation therapy

Trial Locations (28)

1079

Latvian Cancer Center, Riga

1082

Semmelweis University, Budapest

1145

Uzsoki Hospital, Budapest

28041

Hospital Universitario 12 de Octubre, Madrid

29010

Hospital Clinico Universitario - Malaga, Málaga

33100

Universita Degli Studi di Udine, Udine

36100

Ospedale San Bortolo, Vicenza

38100

Centro di Riferimento Oncologico - Aviano, Trento

46009

Instituto Valenciano De Oncologia, Valencia

46010

Hospital Clinico Universitario de Valencia, Valencia

51003

University of Tartu, Tartu

56100

Ospedale St. Santa Chiara, Pisa

70852

Radiotherapy Institute, Ostrava-Poruba

80637

Frauenklinik Vom Roten Kreuz, Munich

115478

Russian Academy of Medical Sciences Cancer Research Center, Moscow

129128

Moscow Clinical Dispenser, Moscow

N. A. Semashko Central Clinical Hospital, Moscow

183047

Regional Oncology Clinic, Murmansk

197758

Petrov Research Institute of Oncology, Saint Petersburg

A-1100

Kaiser Franz Josef Hospital, Vienna

06122

Policlinico Monteluce, Perugia

85-796

Regional Center of Oncology, Bydgoszcz

31-826

Jagiellonian University, Krakow (Cracow)

PL-61-878

Szpital Kliniczny NR 1, Poznan

02-781

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw

SK-81250

St. Elizabeth Cancer Institute Hospital, Bratislava

08025

Hospital de la Santa Cruz I Sant Pau, Barcelona

08035

Hospital General Universitari Vall d'Hebron, Barcelona

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT00003013 - Chemotherapy Plus Surgery in Treating Women With Breast Cancer | Biotech Hunter | Biotech Hunter